1. Home
  2. XERS vs PLPC Comparison

XERS vs PLPC Comparison

Compare XERS & PLPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XERS
  • PLPC
  • Stock Information
  • Founded
  • XERS 2005
  • PLPC 1947
  • Country
  • XERS United States
  • PLPC United States
  • Employees
  • XERS N/A
  • PLPC N/A
  • Industry
  • XERS Biotechnology: Pharmaceutical Preparations
  • PLPC Water Sewer Pipeline Comm & Power Line Construction
  • Sector
  • XERS Health Care
  • PLPC Industrials
  • Exchange
  • XERS Nasdaq
  • PLPC Nasdaq
  • Market Cap
  • XERS 628.7M
  • PLPC 670.0M
  • IPO Year
  • XERS 2018
  • PLPC N/A
  • Fundamental
  • Price
  • XERS $5.06
  • PLPC $140.85
  • Analyst Decision
  • XERS Strong Buy
  • PLPC
  • Analyst Count
  • XERS 6
  • PLPC 0
  • Target Price
  • XERS $6.25
  • PLPC N/A
  • AVG Volume (30 Days)
  • XERS 2.2M
  • PLPC 47.9K
  • Earning Date
  • XERS 05-08-2025
  • PLPC 07-30-2025
  • Dividend Yield
  • XERS N/A
  • PLPC 0.56%
  • EPS Growth
  • XERS N/A
  • PLPC N/A
  • EPS
  • XERS N/A
  • PLPC 7.89
  • Revenue
  • XERS $222,551,000.00
  • PLPC $601,351,000.00
  • Revenue This Year
  • XERS $33.96
  • PLPC N/A
  • Revenue Next Year
  • XERS $19.87
  • PLPC N/A
  • P/E Ratio
  • XERS N/A
  • PLPC $18.08
  • Revenue Growth
  • XERS 29.88
  • PLPC N/A
  • 52 Week Low
  • XERS $1.96
  • PLPC $109.01
  • 52 Week High
  • XERS $6.07
  • PLPC $154.90
  • Technical
  • Relative Strength Index (RSI)
  • XERS 54.35
  • PLPC 54.32
  • Support Level
  • XERS $4.71
  • PLPC $133.27
  • Resistance Level
  • XERS $5.09
  • PLPC $147.50
  • Average True Range (ATR)
  • XERS 0.22
  • PLPC 3.65
  • MACD
  • XERS -0.00
  • PLPC 0.65
  • Stochastic Oscillator
  • XERS 58.93
  • PLPC 59.76

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

About PLPC Preformed Line Products Company

Preformed Line Products Co is a designer and manufacturer of products and systems for constructing and maintaining overhead and underground networks for energy, telecommunication, cable operators, data communication, and other industries. In addition, it provides solar hardware systems and mounting hardware for a variety of solar power applications. Its products consist of Energy Products, Communications Products, and Special Industries Products. The company's majority of the revenue is derived from the sale of products in The Americas with operations also in PLP-USA, Europe, the Middle East and Africa, and Asia-Pacific. The revenue gets driven by Energy products which comprise protecting transmission conductors, spacers, spacer-dampers, and Stockbridge dampers.

Share on Social Networks: